Actinium Pharmaceuticals, Inc.

๐Ÿ“ New York, United States๐Ÿ—“ Founded 2000๐Ÿ‘ฅ 58 employees๐Ÿ’ฐ Last funded 1992
Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2000
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Actinium Pharmaceuticals, Inc.?
Actinium Pharmaceuticals, Inc. has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Actinium Pharmaceuticals, Inc. last raise funding?
The most recent investment in Actinium Pharmaceuticals, Inc. recorded on gritt.io was in 1992.
When was Actinium Pharmaceuticals, Inc. founded?
Actinium Pharmaceuticals, Inc. was founded in 2000.
What industry is Actinium Pharmaceuticals, Inc. in?
Actinium Pharmaceuticals, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Actinium Pharmaceuticals, Inc. based?
Actinium Pharmaceuticals, Inc. is headquartered in New York, United States.